Law Offices of Howard G. Smith Announces a Shareholder Class Action Lawsuit Has Been Filed against Intercept Pharmaceuticals, Inc. Business Wire BENSALEM, Pa. -- February 25, 2014 Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all purchasers of the securities of Intercept Pharmaceuticals, Inc. (“Intercept” or the “Company”) (NASDAQ:ICPT) between January 9, 2014 and January 10, 2014, inclusive (the “Class Period”). Intercept is a development stage biopharmaceutical company, focused on the development and commercialization of novel therapeutics to treat chronic liver diseases utilizing Intercept’s proprietary bile acid chemistry. The Company’s primary drug compound, obeticholic acid (“OCA”), is in various stages of clinical development for the treatment of cirrhosis and other chronic liver diseases. The complaint alleges that the Company’s January 9, 2014, and January 10, 2014, announcements concerning the Phase 2 clinical trial of OCA for treatment of non-alcoholic steatohepatitis failed to disclose material information. On January 10, 2014, the National Institutes of Health’s National Institute of Diabetes and Digestive Kidney Diseases issued a statement that although the efficacy primary endpoint for OCA had already been met, study participants suffered disproportionate levels of lipid abnormalities. Following this news, Intercept stock dropped from its $445.83 per share closing price on January 10, 2014, to a closing price of $255.12 per share on January 14, 2014. If you purchased Intercept securities during the Class Period, you have until April 22, 2014, to move the Court to serve as lead plaintiff; however, you must meet certain legal requirements. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to email@example.com, or visit our website at http://www.howardsmithlaw.com. Contact: Law Offices of Howard G. Smith Howard G. Smith, Esquire (215) 638-4847 (888) 638-4847 firstname.lastname@example.org www.howardsmithlaw.com
Law Offices of Howard G. Smith Announces a Shareholder Class Action Lawsuit Has Been Filed against Intercept Pharmaceuticals,
Press spacebar to pause and continue. Press esc to stop.